[go: up one dir, main page]

Yamaguchi et al., 1999 - Google Patents

Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding

Yamaguchi et al., 1999

View HTML
Document ID
15796030820267534705
Author
Yamaguchi N
Anand‐Apte B
Lee M
Sasaki T
Fukai N
Shapiro R
Que I
Lowik C
Timpl R
Olsen B
Publication year
Publication venue
The EMBO journal

External Links

Snippet

Endostatin, produced as recombinant protein in human 293‐EBNA cells, inhibits the migration of human umbilical vein endothelial cells (HUVECs) in response to vascular endothelial growth factor (VEGF) in a dose‐dependent manner and prevents the …
Continue reading at www.embopress.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Similar Documents

Publication Publication Date Title
Yamaguchi et al. Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding
Sasaki et al. Structure, function and tissue forms of the C‐terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin
Miao et al. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-β-dependent and-independent mechanisms
Roach et al. Preparation of a monoclonal antibody specific for the class I isotype of β‐tubulin: The β isotypes of tubulin differ in their cellular distributions within human tissues
Lampasona et al. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Pober et al. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
Smith et al. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene.
Chiquet-Ehrismann et al. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues.
Marneros et al. Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function
JP4397922B2 (en) Senescent cell-derived DNA synthesis inhibitor
JP2007051150A (en) Connective tissue growth factor
JP2002512038A (en) Methods for inhibiting tumor invasion or spread in a subject
JP2002505873A (en) Vascular endothelial growth factor 2
SK112996A3 (en) Firoblast growth factor-10
Castronovo et al. Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside binding lectin
Hocking et al. A small chimeric fibronectin fragment accelerates dermal wound repair in diabetic mice
Reynolds et al. Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by ‘autoantigen complementarity’
AU737694B2 (en) Novel osteopontin derived chemotactic peptides and methods of use
Zhang et al. mRNA vaccine against fibroblast activation protein ameliorates murine models of inflammatory arthritis
US5453489A (en) Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
US5905146A (en) DNA binding protein S1-3
Kefalides et al. Identification of antigenic epitopes in type IV collagen by use of synthetic peptides
Wei et al. Epitope specificity of monoclonal and polyclonal antibodies to human elastin
Kobayashi et al. Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor
AU765126B2 (en) Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer